Literature DB >> 24726792

Airborne manganese as dust vs. fume determining blood levels in workers at a manganese alloy production plant.

Robert M Park1, Mary Baldwin2, Maryse F Bouchard3, Donna Mergler2.   

Abstract

The appropriate exposure metrics for characterizing manganese (Mn) exposure associated with neurobehavioral effects have not been established. Blood levels of Mn (B-Mn) provide a potentially important intermediate marker of Mn airborne exposures. Using data from a study of a population of silicon- and ferro-manganese alloy production workers employed between 1973 and 1991, B-Mn levels were modeled in relation to prior Mn exposure using detailed work histories and estimated respirable Mn concentrations from air-sampling records. Despite wide variation in exposure levels estimated for individual jobs, duration of employment (exposure) was itself a strong predictor of B-Mn levels and strongest when an 80-day half-life was applied to contributions over time (t=6.95, 7.44, respectively; p<10(-5)). Partitioning exposure concentrations based on process origin into two categories: (1) "large" respirable particulate (Mn-LRP) derived mainly from mechanically generated dust, and (2) "small" respirable particulate (Mn-SRP) primarily electric furnace condensation fume, revealed that B-Mn levels largely track the small, fume exposures. With a half-life of 65 days applied in a model with cumulative exposure terms for both Mn-LRP (t=-0.16, p=0.87) and Mn-SRP (t=6.45, p<10(-5)), the contribution of the large-size fraction contribution was negligible. Constructing metrics based on the square root of SRP exposure concentrations produced a better model fit (t=7.87 vs. 7.44, R(2)=0.2333 vs. 0.2157). In a model containing both duration (t=0.79, p=0.43) and (square root) fume (t=2.47, p=0.01) metrics, the duration term was a weak contributor. Furnace-derived, small respirable Mn particulate appears to be the primary contributor to B-Mn levels, with a dose-rate dependence in a population chronically exposed to Mn, with air-concentrations declining in recent years. These observations may reflect the presence of homeostatic control of Mn levels in the blood and other body tissues and be useful in assessing Mn exposures for evaluating neurotoxic effects. Published by Elsevier B.V.

Entities:  

Keywords:  Blood manganese; Half-life; Manganese; Manganese alloy production; Respiratory particle size

Mesh:

Substances:

Year:  2014        PMID: 24726792      PMCID: PMC4552042          DOI: 10.1016/j.neuro.2014.03.006

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  24 in total

1.  Exposure-response relationship and risk assessment for cognitive deficits in early welding-induced manganism.

Authors:  Robert M Park; Rosemarie M Bowler; Harry A Roels
Journal:  J Occup Environ Med       Date:  2009-10       Impact factor: 2.162

2.  Analysis of manganese tracer kinetics and target tissue dosimetry in monkeys and humans with multi-route physiologically based pharmacokinetic models.

Authors:  Jeffry D Schroeter; Andy Nong; Miyoung Yoon; Michael D Taylor; David C Dorman; Melvin E Andersen; Harvey J Clewell
Journal:  Toxicol Sci       Date:  2010-12-27       Impact factor: 4.849

3.  Manganese neurotoxicity, a continuum of dysfunction: results from a community based study.

Authors:  D Mergler; M Baldwin; S Bélanger; F Larribe; A Beuter; R Bowler; M Panisset; R Edwards; A de Geoffroy; M P Sassine; K Hudnell
Journal:  Neurotoxicology       Date:  1999 Apr-Jun       Impact factor: 4.294

4.  Neuropsychiatric symptoms and past manganese exposure in a ferro-alloy plant.

Authors:  Maryse Bouchard; Donna Mergler; Mary Baldwin; Michel Panisset; Harry A Roels
Journal:  Neurotoxicology       Date:  2006-08-12       Impact factor: 4.294

Review 5.  Biomarkers of manganese intoxication.

Authors:  Wei Zheng; Sherleen X Fu; Ulrike Dydak; Dallas M Cowan
Journal:  Neurotoxicology       Date:  2010-10-12       Impact factor: 4.294

6.  Neurobehavioral functioning after cessation of manganese exposure: a follow-up after 14 years.

Authors:  M Bouchard; D Mergler; M Baldwin; M Panisset; R Bowler; H A Roels
Journal:  Am J Ind Med       Date:  2007-11       Impact factor: 2.214

7.  Manganese cumulative exposure and symptoms: a follow-up study of alloy workers.

Authors:  Maryse Bouchard; Donna Mergler; Mary E Baldwin; Michel Panisset
Journal:  Neurotoxicology       Date:  2008-05-02       Impact factor: 4.294

Review 8.  Manganese and Parkinson's disease: a critical review and new findings.

Authors:  Tomás R Guilarte
Journal:  Environ Health Perspect       Date:  2010-04-19       Impact factor: 9.031

9.  Multi-dose-route, multi-species pharmacokinetic models for manganese and their use in risk assessment.

Authors:  Melvin E Andersen; David C Dorman; Harvey J Clewell; Michael D Taylor; Andy Nong
Journal:  J Toxicol Environ Health A       Date:  2010

10.  Translocation of inhaled ultrafine manganese oxide particles to the central nervous system.

Authors:  Alison Elder; Robert Gelein; Vanessa Silva; Tessa Feikert; Lisa Opanashuk; Janet Carter; Russell Potter; Andrew Maynard; Yasuo Ito; Jacob Finkelstein; Günter Oberdörster
Journal:  Environ Health Perspect       Date:  2006-08       Impact factor: 9.031

View more
  2 in total

1.  Manganese and neurobehavioral impairment. A preliminary risk assessment.

Authors:  Robert M Park; Shannon L Berg
Journal:  Neurotoxicology       Date:  2017-08-10       Impact factor: 4.294

2.  Impact of air manganese on child neurodevelopment in East Liverpool, Ohio.

Authors:  Erin N Haynes; Heidi Sucharew; Timothy J Hilbert; Pierce Kuhnell; Alonzo Spencer; Nicholas C Newman; Roxanne Burns; Robert Wright; Patrick J Parsons; Kim N Dietrich
Journal:  Neurotoxicology       Date:  2017-09-06       Impact factor: 4.294

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.